S.3187 - Synthetic Drug Abuse Prevention Act of 2012
A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. view all titles (24)
All Bill Titles
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed senate.
- Short: Prescription Drug User Fee Amendments of 2012 as passed senate.
- Short: Medical Device User Fee Amendments of 2012 as passed senate.
- Short: Generic Drug User Fee Amendments of 2012 as passed senate.
- Short: Biosimilar User Fee Act of 2012 as passed senate.
- Short: Food and Drug Administration Safety and Innovation Act as passed senate.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as passed house.
- Short: Prescription Drug User Fee Amendments of 2012 as passed house.
- Short: Medical Device User Fee Amendments of 2012 as passed house.
- Short: Generic Drug User Fee Amendments of 2012 as passed house.
- Short: Biosimilar User Fee Act of 2012 as passed house.
- Short: Food and Drug Administration Safety and Innovation Act as passed house.
- Official: A bill to amend the Federal Food, Drug, and Cosmetic Act to revise and extend the user-fee programs for prescription drugs and medical devices, to establish user-fee programs for generic drugs and biosimilars, and for other purposes. as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as introduced.
- Short: Biosimilar User Fee Act of 2012 as introduced.
- Short: Generic Drug User Fee Amendments of 2012 as introduced.
- Short: Medical Device User Fee Amendments of 2012 as introduced.
- Short: Prescription Drug User Fee Amendments of 2012 as introduced.
- Short: Food and Drug Administration Safety and Innovation Act as enacted.
- Short: Biosimilar User Fee Act of 2012 as enacted.
- Short: Generic Drug User Fee Amendments of 2012 as enacted.
- Short: Medical Device User Fee Amendments of 2012 as enacted.
- Short: Prescription Drug User Fee Amendments of 2012 as enacted.
- Short: Synthetic Drug Abuse Prevention Act of 2012 as enacted.
This Bill currently has no wiki content. If you would like to create a wiki entry for this bill, please Login, and then select the wiki tab to create it.
Interests that support this bill:
- Pharmacists
- Physicians
- Medical supplies manufacturing & sales
- Biotech products & research
- Pharmaceutical manufacturing
- Health, Education & Human Resources
- Small business associations
- Chemicals
- Health & welfare policy
- Consumer groups
- Non-Profits
- Non-profit foundations
Top recipients for ALL supporting interest groups
| Name | Amount Received | Vote On Passage |
|---|---|---|
| Sen. Harry Reid [D, NV] | $511,085 | Aye |
| Sen. Richard Burr [R, NC] | $301,919 | Aye |
| Sen. Charles E. Schumer [D, NY] | $245,500 | Aye |
| Sen. Mark Kirk [R, IL] | $238,160 | Abstain |
| Sen. Ron Wyden [D, OR] | $208,400 | Aye |
| Sen. Kirsten Gillibrand [D, NY] | $208,011 | Aye |
| Sen. Patty Murray [D, WA] | $197,267 | Aye |
| Sen. Roy Blunt [R, MO] | $190,200 | Aye |
| Sen. Rob Portman [R, OH] | $163,495 | Aye |
| Sen. David Vitter [R, LA] | $157,451 | Aye |
| Rep. Frank Pallone Jr. [D, NJ-6] | $164,551 | |
| Rep. Anna G. Eshoo [D, CA-18] | $163,500 | |
| Rep. Dave Camp [R, MI-4] | $161,319 | |
| Rep. Steny H. Hoyer [D, MD-5] | $158,050 | |
| Rep. Vern Buchanan [R, FL-16] | $155,734 | |
| Rep. Michael E. Capuano [D, MA-7] | $146,851 | |
| Rep. Tom Price [R, GA-6] | $144,550 | |
| Rep. Michael C. Burgess [R, TX-26] | $132,525 | |
| Rep. Jim Matheson [D, UT-4] | $132,300 | |
| Rep. Eric Cantor [R, VA-7] | $131,500 |
Specific Organizations Supporting S.3187
- Society of Chemical Manufacturers and Affiliates
- Mylan Inc.
- Small Business and Entrepreneurship Council
- National Health Council
- PEW Charitable Trust
- Consumers Union
- Pharmaceutical Manufacturers Association
- Generic Pharmaceutical Association
- Advanced Medical Technology Association
- American Foundation for the Blind
- National Alliance on Mental Illness
- The Infectious Diseases Society of America
- National Community Pharmacists Association
- Biotechnology Industry Organization
- Pharmaceutical Industry Labor Management Association
- American Academy of Pediatrics
Campaign contribution data provided by OpenSecrets.org, the nonpartisan guide to money in politics. Contribution data is constantly being updated and this data may not be entirely up to date.

U.S. Congress - S.3187 Synthetic Drug Abuse Prevention Act of 2012




